These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8954825)

  • 21. Cyclophilin-facilitated bradykinin inactivation in the perfused rat lung.
    Merker MP; Dawson CA
    Biochem Pharmacol; 1995 Dec; 50(12):2085-91. PubMed ID: 8849336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies study.
    Blais C; Drapeau G; Raymond P; Lamontagne D; Gervais N; Venneman I; Adam A
    Am J Physiol; 1997 Nov; 273(5):H2263-71. PubMed ID: 9374762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recovery and conversion of kinins in exsanguinated rat preparations.
    Prado JL; Limãos EA; Roblero J; Freitas JO; Prado ES; Paiva AC
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):191-205. PubMed ID: 1186919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
    Ward PE; Chow A; Drapeau G
    Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of bradykinin by the rat coronary vascular bed.
    Dumoulin MJ; Adam A; Blais C; Lamontagne D
    Cardiovasc Res; 1998 Apr; 38(1):229-36. PubMed ID: 9683926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of canine bradykinin receptors in prostatic culture and in isolated prostate.
    Srinivasan D; Burbach LR; Daniels DV; Ford AP; Bhattacharya A
    Br J Pharmacol; 2004 May; 142(2):297-304. PubMed ID: 15155537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presystemic bradykinin metabolism in sheep and rat nasal homogenates.
    Chung FY; Donovan MD
    J Pharm Sci; 1995 Jul; 84(7):794-8. PubMed ID: 7562426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of enalaprilat on bradykinin and des-Arg9-bradykinin release following reperfusion of the ischaemic rat heart.
    Lamontagne D; Nadeau R; Adam A
    Br J Pharmacol; 1995 Jun; 115(3):476-8. PubMed ID: 7582459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations.
    Lembeck F; Griesbacher T; Eckhardt M
    Br J Pharmacol; 1990 May; 100(1):49-54. PubMed ID: 2164861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of kinin analogues by ramiprilat is exclusively related to their degradation.
    Dendorfer A; Reibetamann S; Wolfrum S; Raasch W; Dominiak P
    Hypertension; 2001 Jul; 38(1):142-6. PubMed ID: 11463775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of potent bradykinin agonists containing a benzothiazepine moiety.
    Amblard M; Daffix I; Bedos P; Bergé G; Pruneau D; Paquet JL; Luccarini JM; Bélichard P; Dodey P; Martinez J
    J Med Chem; 1999 Oct; 42(20):4185-92. PubMed ID: 10514288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The release and vascular action of bradykinin in the isolated perfused bovine udder.
    Zeitlin IJ; Eshraghi HR
    J Physiol; 2002 Aug; 543(Pt 1):221-31. PubMed ID: 12181294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the angiotensin-converting enzyme and the kinin B2 receptor in the rabbit jugular vein: modulation of contractile response to bradykinin.
    Gobeil F; Hallé S; Blais PA; Regoli D
    Can J Physiol Pharmacol; 2002 Feb; 80(2):153-63. PubMed ID: 11934258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ramiprilat attenuates hypoxia/reoxygenation injury to cardiac myocytes via a bradykinin-dependent mechanism.
    Wall TM; Linseman DA; Hartman JC
    Eur J Pharmacol; 1996 Jun; 306(1-3):165-74. PubMed ID: 8813629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase.
    Kokkonen JO; Kuoppala A; Saarinen J; Lindstedt KA; Kovanen PT
    Circulation; 1999 Apr; 99(15):1984-90. PubMed ID: 10209002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How bradykinin alters the lipid membrane structure: a spin label comparative study with bradykinin fragments and other cations.
    Turchiello RF; Juliano L; Ito AS; Lamy-Freund MT
    Biopolymers; 2000 Sep; 54(3):211-21. PubMed ID: 10861382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fate of bradykinin on the rat liver when administered by the venous or arterial route.
    Gioli-Pereira L; Nascimento EA; Santos EL; Bracht A; Juliano MA; Pesquero JB; Borges DR; Kouyoumdjian M
    J Gastroenterol Hepatol; 2005 Mar; 20(3):463-73. PubMed ID: 15740493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A CD and an NMR study of multiple bradykinin conformations in aqueous trifluoroethanol solutions.
    Cann JR; Liu X; Stewart JM; Gera L; Kotovych G
    Biopolymers; 1994 Jul; 34(7):869-78. PubMed ID: 8054469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformationally Regulated Peptide Bond Cleavage in Bradykinin.
    Fuller DR; Conant CR; El-Baba TJ; Brown CJ; Woodall DW; Russell DH; Clemmer DE
    J Am Chem Soc; 2018 Aug; 140(30):9357-9360. PubMed ID: 30028131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.